Search Within

Matthew J Matasar

  1. "Center for Hematologic Malignancies"
  2. "2016"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (6)
  3. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (18)
  2. Department of Medicine (18)
  3. Hematologic Malignancies, Division of (18)
  4. Lymphoma (18)
  5. Survivorship Research (18)
  6. Epidemiology and Biostatistics (9)

More Groups

People
  1. Craig Moskowitz (9)
  2. Alison Moskowitz (7)
  3. Ariela Noy (7)
  4. Andrew Zelenetz (6)
  5. Craig Sauter (6)
  6. Maria Palomba (6)

More People

Years
  1. 2016 (18)
Publications
  1. Blood (7)
  2. Journal of Clinical Oncology (3)
  3. Biology of Blood and Marrow Transplantation (2)
  4. BMJ Open (1)
  5. British Journal of Haematology (1)
  6. Haematologica (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. American Society of Clinical Oncology (3)
  3. Elsevier Inc. (2)
  4. BMJ Publishing Group Ltd. (1)
  5. Ferrata Storti Foundation (1)
  6. John Wiley & Sons (1)

More Publishers

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-cancer cardiovascular risk factors and anthracycline-related cardiotoxicity among non-Hodgkin lymphoma survivors
    Meeting Abstract

    Salz, T.; Brown, P.; Zabor, E. C.; Dalton, S. O.; Raghunathan, N. J.; Matasar, M. J.; Steingart, R.; Vickers, A. J.; Oeffinger, K. C.; Johansen, C.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Real-world health care utilization and costs among patients newly initiating systemic therapy for chronic lymphocytic leukemia (CLL) in the United States
    Meeting Abstract

    Matasar, M. J.; Byfield, S. D.; Blauer-Peterson, C.; Montez, M.; Reyes, C.; Masaquel, A.
    Blood (2016)

    Fulltext@MSK | Save
  • A Phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M.; Lynch, P.; Scheuerman, M.; Kumar, A.; Gerecitano, J. F.; Zelenetz, A. D.; Hamlin, P. A. Jr; Noy, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • What is the cost of disease progression among patients with indolent or aggressive non-Hodgkin lymphoma (NHL)?
    Meeting Abstract

    Engel-Nitz, N.; Byfield, S. D.; Bancroft, T.; Amy, A. J.; Reyes, C.; Chen, M.; Matasar, M. J.
    Blood (2016)

    Fulltext@MSK | Save
  • Distress and perceived impact on well-being for low- or intermediate-risk and high-risk patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Buzaglo, J. S.; Miller, M. F.; Karten, C.; Weiss, E. S.; Tomlinson, B.; Andersen, B. L.; Matasar, M. J.; Byrd, J. C.; Flowers, C.
    Blood (2016)

    Fulltext@MSK | Save
  • Outcomes of follicular lymphoma patients by dynamic FLIPI at diagnosis and initial treatment in the post-rituximab era
    Meeting Abstract

    Batlevi, C.; Alperovich, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Benchmark of progression free survival for multiple lines of therapy in follicular lymphoma treated in the rituximab era
    Meeting Abstract

    Alperovich, A.; Batlevi, C.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • PET-adapted therapy with brentuximab vedotin and augmented ICE for relapsed/refractory Hodgkin lymphoma - Lack of Improvement with 3 versus 2 cycles of weekly brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Schòˆder, H.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Pattern and prognostic implications of cardiac metastases among patients with advanced systemic cancer assessed with cardiac magnetic eesonance imaging
    Journal Article

    Pun, S. C.; Plodkowski, A.; Matasar, M. J.; Lakhman, Y.; Halpenny, D. F.; Gupta, D.; Moskowitz, C.; Kim, J.; Steingart, R.; Weinsaft, J. W.
    Journal of the American Heart Association (2016)

    Fulltext@MSK | Save
  • Risk factors predicting outcomes for primary refractory Hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation
    Journal Article

    Shah, G. L.; Yahalom, J.; Matasar, M. J.; Verwys, S. L.; Goldman, D. A.; Bantilan, K. S.; Zhang, Z.; McCall, S. J.; Moskowitz, A. J.; Moskowitz, C. H.
    British Journal of Haematology (2016)

    Fulltext@MSK | Save